Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 7/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.51 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.51 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.51 |
| ▸ | HTR1A | P08908 | 3/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.51 |
| ▸ | HRH1 | P35367 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.51 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.51 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.51 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.51 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.51 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.51 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.51 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18934406 | 0.88 | CYP2D6 (0.50) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| SCHEMBL1725271 | 0.79 | CYP2D6 (0.63) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| SCHEMBL18934407 | 0.74 | CYP2D6 (0.49) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| Trihexyphenidyl SCHEMBL34645 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| Trihexyphenidyl SCHEMBL1320615 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| Trihexyphenidyl SCHEMBL34646 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| Procyclidine SCHEMBL147344 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| (S)-Procyclidine SCHEMBL519431 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| Cycrimine SCHEMBL249004 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 | |
| (R)-Procyclidine SCHEMBL15305878 | 0.68 | CHRM2 (1.00) | CHRM2CHRM1CYP2D6CHRM3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170157168-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | ALFAMA-INVESTIGAÇÃO E DESENVOLVIMENTO DE PRODUTOS FARMACÊUTICOS LDA (PT) | 2017-06-08 | — | — | US | disclosed |
| US-9023402-B2 | Method for treating a mammal by administration of a compound having the ability to release CO | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. (PT) | 2015-05-05 | — | — | US | disclosed |
| US-20140212514-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | ALFAMA - INVESTIGACAO E DESENVOLVIMENTO DE PRODUTOS FARMACEUTICOS, LDA. (PT) | 2014-07-31 | — | — | US | disclosed |
| EP-2182961-B1 | PREVENTION OF GASTRIC ULCERY BY CARBON MONOXIDE | ALFAMA INVESTIGACAO E DESENVOLVIMENTO DE PRODUCTOS FARMACEUTICOS LDA (PT) | 2012-05-02 | — | — | EP | disclosed |
| US-20110237546-A1 | METHOD FOR TREATING A MAMMAL BY ADMINISTRATION OF A COMPOUND HAVING THE ABILITY TO RELEASE CO | ALFAMA - INVESTIGACAO E DESENVOLVIMENTO DE PRODUTOS FARMACEUTICOS LDA (PT) | 2011-09-29 | — | — | US | disclosed |
| US-7964220-B2 | Method for treating a mammal by administration of a compound having the ability to release CO | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. (PT) | 2011-06-21 | — | — | US | disclosed |
| US-7964220-B2 | Method for treating a mammal by administration of a compound having the ability to release CO | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. (PT) | 2011-06-21 | — | — | US | disclosed |
| US-20110038955-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | ALFAMA - INVESTIGACAO E DESENVOLVIMENTO DE PRODUTOS FARMACEUTICOS, LDA. (PT) | 2011-02-17 | — | — | US | disclosed |
| US-20100196516-A1 | TREATMENT OF INFECTIONS BY CARBON MONOXIDE | ALFAMA-Investigacao e Desenvolvimento de produtos Farmaceuticos, Lda (PT) | 2010-08-05 | — | — | US | disclosed |
| US-20100196516-A1 | TREATMENT OF INFECTIONS BY CARBON MONOXIDE | ALFAMA-Investigacao e Desenvolvimento de produtos Farmaceuticos, Lda (PT) | 2010-08-05 | — | — | US | disclosed |
| EP-2042181-A1 | Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. (PT) | 2009-04-01 | — | — | EP | disclosed |
| WO-2009013612-A1 | PREVENTION OF GASTRIC ULCERY BY CARBON MONOXIDE | ALFAMA - INVESTIGAÇÃO E DESENVOLVIMENTO DE PRODUTOS FARMACÊUTICOS, LDA. (PT) | 2009-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110038955-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | PTGS1, PTGS2, NOS2 | CHRM2 2171/4885CHRM1 1339/4885CYP2D6 439/4885 |
| US-20110237546-A1 | METHOD FOR TREATING A MAMMAL BY ADMINISTRATION OF A COMPOUND HAVING THE ABILITY TO RELEASE CO | PTGS1, PTGES, TNF | CHRM2 139/4885CHRM1 122/4885CYP2D6 1534/4885 |
| US-20170157168-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | PTGS1, PTGS2, NOS2 | CHRM2 2171/4885CHRM1 1339/4885CYP2D6 439/4885 |
| US-20100196516-A1 | TREATMENT OF INFECTIONS BY CARBON MONOXIDE | MB, IFNG, CORO1C | CHRM2 513/4885CHRM1 539/4885CYP2D6 701/4885 |
| US-20140212514-A1 | PREVENTION OF GASTRIC ULCER BY CARBON MONOXIDE | PTGS1, PTGS2, NOS2 | CHRM2 2171/4885CHRM1 1339/4885CYP2D6 439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.